3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
9
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
HER2-positive Breast Cancer
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Interventions
enzalutamide
4
Docetaxel
2
pembrolizumab
1
olaparib
1
lenvatinib
1
inavolisib
1
belzutifan
1
abiraterone
1
Prednisone
1
PF06821497
1
Lutetium-177
1
Lutetium
1
Gonadotropin-Releasing Hormone
1
Etoposide
1
Dexamethasone
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Metastatic Castration-Resistant Prostate Cancer
×
inavolisib
×
Clear all
NCT07287150
2026-05-06
InavoPC
Hoffmann-La Roche
Phase 2
Recruiting
100 enrolled